# PegvisOMant and the Immune SystEm (PROMISE)

> **NCT05069324** · — · COMPLETED · sponsor: **University of Roma La Sapienza** · enrollment: 62 (actual)

## Conditions studied

- Acromegaly

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05069324
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-29
- **Primary completion:** 2024-12-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069324, "PegvisOMant and the Immune SystEm (PROMISE)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05069324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*